Trial Profile
A Study to Evaluate the Pharmacokinetics of BMS-986177 From Form A and Form B in Healthy Participants
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Mar 2018
Price :
$35
*
At a glance
- Drugs Milvexian (Primary)
- Indications Thrombosis
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 13 Mar 2018 Status changed from recruiting to completed.
- 07 Dec 2017 New trial record